eTheRNA
Cambridge, United States· Est.
eTheRNA develops mRNA-based immunotherapies and vaccines for infectious diseases and cancer using its proprietary lipid nanoparticle delivery technology.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $39M
About
eTheRNA develops mRNA-based immunotherapies and vaccines for infectious diseases and cancer using its proprietary lipid nanoparticle delivery technology.
RNA TherapeuticsVaccinesInfectious Disease
Funding History
1Total raised:$39M
IPO$39M